Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Single 225μg/Kg Dose Treatment with Eptacog Beta (Factor VIIa, Recombinant) Results in Rapid Hemostasis in Joint Bleeds for Persons with Hemophilia Α or Β with Inhibitors: A PERSEPT1 Subset Analysis

Janna M. Journeycake, MD, Cedric Hermans, MDMRCP,PhD, Jonathan M. Ducore, MD MPH, Miguel A. Escobar, MD, Guy Young, MD, Michael Wang, MD, Doris Quon, MD PhD, W Allan Alexander, MD, Ian S Mitchell, PhD, Ahmad Al-Sabbagh, MD, Daniel Bonzo, PhD

Blood (2020) 136 (Supplement 1): 2–3.

https://doi.org/10.1182/blood-2020-136443

Published: 2020

Journal Articles

Recognizing Hereditary TTP in Infants and Children

Anam Siddiqui, Azra Borogovac, MD, James N. George, MD, Janna M. Journeycake, MD

Blood (2020) 136 (Supplement 1): 6–7.

https://doi.org/10.1182/blood-2020-133918

Published: 2020

Journal Articles

Dosing, Patient Satisfaction and Other Patient-Reported Outcomes after Switching to Rurioctocog Alfa Pegol in Athn 2: A Longitudinal, Observational Study of Previously Treated Hemophilia Patients Switching Coagulation Replacement Factor Products

Janna M. Journeycake, MD, Michael Recht, MD PhD, Christine Guelcher, Hemostasis RN-BC, MS, PPCNP-BC, Ellis J. Neufeld, Margaret V. Ragni, MDMPH, Robert F. Sidonio, Jr., MDMSc, Cliff Takemoto, Michael D Tarantino, MD, Dunlei Cheng, PhD, Susan U. Lattimore, Jorge Caicedo, Michael Denne, PharmD

Blood (2020) 136 (Supplement 1): 17–18.

https://doi.org/10.1182/blood-2020-138898

Published: 2020

Journal Articles

Role of Low Albumin Levels in Pediatric Patients with Central Venous Catheters at Risk for Thrombosis

Neha Bhasin, MD, Denise Roe, DrPH, Janna M. Journeycake, MD, Chelsea Large, Kathylynn Saboda, MS, Beth Boulden Warren, MD MS, Marilyn J Manco-Johnson, MD, David T. Harris, PhD, Michael Badowski, PhD, Lynn Gerald, Vivian Moreno, Steven R. Lentz, MD PhD

Blood (2019) 134 (Supplement_1): 3650.

https://doi.org/10.1182/blood-2019-124858

Published: 2019

Journal Articles

Lack of Inhibitor Development in the American Thrombosis and Hemostasis Network (ATHN)-2 Factor Switching Study: Preliminary Report of Primary Outcome

Robert F. Sidonio, Jr., MD MSc, Dunlei Cheng, PhD, Christine Guelcher, PPCNP-BC, Janna M. Journeycake, MD, Susan U Lattimore, Clifford Takemoto, MD, Michael D. Tarantino, MD, Crystal Watson, Ellis J. Neufeld, MD, Carol Fedor, RN

Blood (2019) 134 (Supplement_1): 1114.

https://doi.org/10.1182/blood-2019-128612

Published: 2019

Journal Articles

A Retrospective Chart Review to Assess Indications, Risk Factors and Complications Associated with the Use of Indwelling Catheters in Pediatric Patients with Sickle Cell Disease - a Single Institution Experience

Chibuzo Ilonze, MD, Michael P Anderson, PhD, Alexander Stubblefield, Janna M. Journeycake, MD, Arpan Sinha, MBBS, MD

Blood (2019) 134 (Supplement_1): 4856.

https://doi.org/10.1182/blood-2019-130467

Published: 2019

Journal Articles

Prospective Diagnosis of VWD in a Large Cohort of Patients with Bleeding Symptoms through the Zimmerman Program

Veronica H Flood, MD, Pamela A Christopherson, Joan Cox Gill, MD, Kenneth Dale Friedman, MD, Sandra L Haberichter, PhD, Jorge Di Paola, MD, Paula D. James, MD, Janna M. Journeycake, MD, Steven R. Lentz, MD PhD, Cindy A. Leissinger, MD, Margaret V. Ragni, MD MPH, Madhvi Rajpurkar, MD, Jonathan C. Roberts, MD, Amy Shapiro, Robert F. Sidonio, Robert R Montgomery, MD, Thomas C. Abshire, MD

Blood (2018) 132 (Supplement 1): 979.

https://doi.org/10.1182/blood-2018-99-110650

Published: 2018

Journal Articles

Prospective Evaluation of ISTH-BAT As a Predictor of Bleeding Disorder in Adolescent Girls with Heavy Menstrual Bleeding

Shilpa Jain, MD MPH, Ravi Sarode, MD, Janna M. Journeycake, MD, Ayesha Zia, MD

Blood (2016) 128 (22): 1402.

https://doi.org/10.1182/blood.V128.22.1402.1402

Published: 2016

Journal Articles

Comprehensive Evaluation of Bleeding Disorders in Adolescents with Heavy Menstrual Bleeding

Ayesha Zia, MD, Janna M. Journeycake, MD, Shilpa Jain, MD MPH, Ravi Sarode, MD

Blood (2016) 128 (22): 876.

https://doi.org/10.1182/blood.V128.22.876.876

Published: 2016

Journal Articles

Durability of ITI Utilizing Rfviiifc

Margaret V. Ragni, MD, Lynn M. Malec, MD, Janna M. Journeycake, MD

Blood (2016) 128 (22): 3793.

https://doi.org/10.1182/blood.V128.22.3793.3793

Published: 2016

Journal Articles

Thrombin Generation in Children after Acute Venous Thromboembolism

Ayesha Zia, MD, Janna M. Journeycake, MD, Ravi Sarode, MD

Blood (2015) 126 (23): 2311.

https://doi.org/10.1182/blood.V126.23.2311.2311

Published: 2015

Journal Articles

Immune Tolerance Induction Using Rfviiifc (Eloctate)

Lynn M. Malec, MD MS, Margaret V Ragni, Janna M. Journeycake, MD, Michelle Alabek, MS, CGC

Blood (2015) 126 (23): 3531.

https://doi.org/10.1182/blood.V126.23.3531.3531

Published: 2015

Journal Articles

Bleeding risks are higher in children versus adults given prophylactic platelet transfusions for treatment-induced hypoproliferative thrombocytopenia

Cassandra D. Josephson, Suzanne Granger, Susan F. Assmann, Marta-Inés Castillejo, Ronald G. Strauss, Sherrill J. Slichter, Marie E. Steiner, Janna M. Journeycake, Courtney D. Thornburg, James Bussel, Eric F. Grabowski, Ellis J. Neufeld, William Savage, Steven R. Sloan

Blood (2012) 120 (4): 748–760.

https://doi.org/10.1182/blood-2011-11-389569

Published: 2012

Includes: Supplemental data

Journal Articles

Phase II Trial of Rituximab in the Treatment of Inhibitors in Congenital Hemophilia A: Results of the RICH Study

Cindy A. Leissinger, MD, Rebecca Kruse-Jarres, MD, Suzanne Granger, MS, Barbara A Konkle, MD, Margaret V. Ragni, MD, MPH, Janna M. Journeycake, MD, Ellis J. Neufeld, MD, PhD, Cassandra Josephson, MD, Carolyn M. Bennett, MD, MS, Leonard A. Valentino, MD, FAAP, Nigel S. Key, MBChB, Leslie Raffini, MD, Marcela Torres, MD, Joan Cox Gill, MD, Susan Assmann, PhD

Blood (2011) 118 (21): 27.

https://doi.org/10.1182/blood.V118.21.27.27

Published: 2011

Journal Articles

Impact of Persistent Antiphospholipid Antibodies on Symptomatic Thromboembolism In Children: A Systematic Review & Meta-Analysis [Observational Studies]

Gili Kenet, MD, Mariana Bonduel, Anthony Chan, MBBS, FRCPC, FRCPath, Neil Goldenberg, Suzzane Holtzhauer, Alfonso Iorio, Janna M. Journeycake, MD, Ralf Junker, Christoph Male, Mary Patricia Massicotte, MD, Rolf M. Mesters, Paul Monagle, MBBS, MD, MSc, Heleen Van Ommen, Leslie Raffini, MD, Paolo Simioni, Guy Young, MD, Ulrike Nowak-Gottl, MD

Blood (2010) 116 (21): 3169.

https://doi.org/10.1182/blood.V116.21.3169.3169

Published: 2010

Journal Articles

Thrombosis and Thrombophilia in Children with Intestinal Failure Syndromes.

Janna M. Journeycake, MD, Nandini Channabasappa, MD

Blood (2009) 114 (22): 4007.

https://doi.org/10.1182/blood.V114.22.4007.4007

Published: 2009

Journal Articles

Deep Venous Thrombosis Screening of Hemophilia Patients with Central Venous Catheters.

Carrye R. Cost, MD, Kim L. Spencer, MS, RN, CPNP, George R. Buchanan, MD, Janna M. Journeycake, MD

Blood (2008) 112 (11): 2282.

https://doi.org/10.1182/blood.V112.11.2282.2282

Published: 2008

Journal Articles

Down Syndrome as an Independent Risk Factor for Thrombosis in Children.

Janna M. Journeycake, MD, Laura E. Brumley, MD

Blood (2006) 108 (11): 1489.

https://doi.org/10.1182/blood.V108.11.1489.1489

Published: 2006

Journal Articles

Experience with Intravenous Enoxaparin in Critically Ill Infants and Children.

Shelley E. Crary, MD, Heidi Van Orden, Pharm.D., Janna M. Journeycake, M.D.

Blood (2006) 108 (11): 881.

https://doi.org/10.1182/blood.V108.11.881.881

Published: 2006

Journal Articles

Pediatric Norms for Assessment of Upper Venous Post-Thrombotic Syndrome.

Beth M. Boulden, MS, Shelley E. Crary, MD, George R. Buchanan, MD, Janna M. Journeycake, MD

Blood (2005) 106 (11): 4112.

https://doi.org/10.1182/blood.V106.11.4112.4112

Published: 2005

NARROW

Single 225μg/Kg Dose Treatment with Eptacog Beta (Factor VIIa, Recombinant) Results in Rapid Hemostasis in Joint Bleeds for Persons with Hemophilia Α or Β with Inhibitors: A PERSEPT1 Subset Analysis

Recognizing Hereditary TTP in Infants and Children

Dosing, Patient Satisfaction and Other Patient-Reported Outcomes after Switching to Rurioctocog Alfa Pegol in Athn 2: A Longitudinal, Observational Study of Previously Treated Hemophilia Patients Switching Coagulation Replacement Factor Products

Role of Low Albumin Levels in Pediatric Patients with Central Venous Catheters at Risk for Thrombosis

Lack of Inhibitor Development in the American Thrombosis and Hemostasis Network (ATHN)-2 Factor Switching Study: Preliminary Report of Primary Outcome

A Retrospective Chart Review to Assess Indications, Risk Factors and Complications Associated with the Use of Indwelling Catheters in Pediatric Patients with Sickle Cell Disease - a Single Institution Experience

Prospective Diagnosis of VWD in a Large Cohort of Patients with Bleeding Symptoms through the Zimmerman Program

Prospective Evaluation of ISTH-BAT As a Predictor of Bleeding Disorder in Adolescent Girls with Heavy Menstrual Bleeding

Comprehensive Evaluation of Bleeding Disorders in Adolescents with Heavy Menstrual Bleeding

Durability of ITI Utilizing Rfviiifc

Thrombin Generation in Children after Acute Venous Thromboembolism

Immune Tolerance Induction Using Rfviiifc (Eloctate)

Bleeding risks are higher in children versus adults given prophylactic platelet transfusions for treatment-induced hypoproliferative thrombocytopenia

Phase II Trial of Rituximab in the Treatment of Inhibitors in Congenital Hemophilia A: Results of the RICH Study

Impact of Persistent Antiphospholipid Antibodies on Symptomatic Thromboembolism In Children: A Systematic Review & Meta-Analysis [Observational Studies]

Thrombosis and Thrombophilia in Children with Intestinal Failure Syndromes.

Deep Venous Thrombosis Screening of Hemophilia Patients with Central Venous Catheters.

Down Syndrome as an Independent Risk Factor for Thrombosis in Children.

Experience with Intravenous Enoxaparin in Critically Ill Infants and Children.

Pediatric Norms for Assessment of Upper Venous Post-Thrombotic Syndrome.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only